Ganesan Shridar, Silver Daniel P, Greenberg Roger A, Avni Dror, Drapkin Ronny, Miron Alexander, Mok Samuel C, Randrianarison Voahangy, Brodie Steven, Salstrom Jennifer, Rasmussen Theodore P, Klimke Ann, Marrese Christine, Marahrens York, Deng Chu Xia, Feunteun Jean, Livingston David M
The Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
Cell. 2002 Nov 1;111(3):393-405. doi: 10.1016/s0092-8674(02)01052-8.
BRCA1, a breast and ovarian tumor suppressor, colocalizes with markers of the inactive X chromosome (Xi) on Xi in female somatic cells and associates with XIST RNA, as detected by chromatin immunoprecipitation. Breast and ovarian carcinoma cells lacking BRCA1 show evidence of defects in Xi chromatin structure. Reconstitution of BRCA1-deficient cells with wt BRCA1 led to the appearance of focal XIST RNA staining without altering XIST abundance. Inhibiting BRCA1 synthesis in a suitable reporter line led to increased expression of an otherwise silenced Xi-located GFP transgene. These observations suggest that loss of BRCA1 in female cells may lead to Xi perturbation and destabilization of its silenced state.
BRCA1是一种乳腺和卵巢肿瘤抑制因子,在雌性体细胞中,它与失活X染色体(Xi)的标记物共定位于Xi上,并与XIST RNA相关联,这是通过染色质免疫沉淀检测到的。缺乏BRCA1的乳腺癌和卵巢癌细胞显示出Xi染色质结构存在缺陷的证据。用野生型BRCA1重建BRCA1缺陷细胞会导致出现局部XIST RNA染色,而不会改变XIST的丰度。在合适的报告细胞系中抑制BRCA1的合成会导致原本沉默的位于Xi上的绿色荧光蛋白转基因表达增加。这些观察结果表明,雌性细胞中BRCA1的缺失可能导致Xi紊乱及其沉默状态的不稳定。